Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
9.61
-0.21 (-2.14%)
At close: Aug 14, 2026, 4:00 PM EDT
9.62
+0.01 (0.10%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of $200.85 million as of August 14, 2026. Its market cap has increased by 185.17% in one year.
Market Cap
200.85M
Enterprise Value
137.57M
1-Year Change
185.17%
Ranking
Category
Stock Price
$9.61
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from $45.99M to $200.85M, an increase of 336.70%. That is a compound annual growth rate of 34.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 200.85M | 124.93% |
| Dec 31, 2025 | 89.30M | -6.65% |
| Dec 31, 2024 | 95.65M | 160.46% |
| Dec 29, 2023 | 36.73M | 440.53% |
| Dec 30, 2022 | 6.79M | -73.94% |
| Dec 31, 2021 | 26.07M | -43.31% |
| Aug 19, 2021 | 45.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NovaBridge Biosciences | 219.73M |
| Tonix Pharmaceuticals Holding | 214.39M |
| Conexeu Sciences | 213.26M |
| Keros Therapeutics | 211.36M |
| Atrium Therapeutics | 210.91M |
| PepGen | 206.39M |
| Precision BioSciences | 202.04M |
| Invivyd | 202.01M |